TGFBR2, a central component of the TGF-β pathway, is often deleted during carcinogenesis in numerous cancer types, including NSCLC (Wang et al., 2007), and functions as an effective tumor suppressor in NSCLC (Lo Sardo et al., 2021). Here, TGFBR2 is linked to cancer.